News & Events

Meet selectION, Inc. at the 42^ndAnnual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 8^th to 11^th, 2024

December 11, 2023

SAN DIEGO, Dec 11, 2023 – Meet selectION’s management team for an update on selectION’s best-in-class ion channel blockers and the status of the Phase 1b clinical trial in autoimmune…

Meet selectION, Inc. at the BIO-Europe in Munich, on November 6^th to 8^th, 2023

September 25, 2023

Events

SAN DIEGO, Sept 25, 2023 – Meet selectION’s management team for an update on selectION’s best-in-class ion channel blockers and the status of the Phase 1b clinical trial in autoimmune…

BioWorld: Selection waits on efficacy data from trial of Kv1.3 ion channel blocker in atopic dermatitis

June 2, 2023

News

By Cormac Sheridan, Staff Writer – Published by BioWorld™ – The coming months represent a crucial phase in the development of Selection Inc., a U.S.-German firm that is tackling a…

selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis

May 30, 2023

News

Ongoing phase 1b trial is designed to evaluate safety, tolerability, and efficacy of si-544 in T-cell mediated autoimmunity Dosing of MAD stage has been initiated; first results expected for late…

Meet selectION, Inc. at the BIO International Convention in Boston, on June 5^th to 8^th, 2023

May 9, 2023

Events

SAN DIEGO, May 9, 2023 – Meet selectION’s management team for an update on selectION’s best-in-class ion channel blockers and the status of the Phase 1b clinical trial in autoimmune…

Meet selectION, Inc. at the BIO-EUROPE SPRING Conference in Basel, Switzerland, on March 20^th to March 22^nd, 2023

February 9, 2023

Events

SAN DIEGO, February 9, 2023 – Meet selectION’s management team for an update on selectION’s best-in-class ion channel blockers and the status of the clinical work.

Meet selectION, Inc. at the Global Life Science Partnering & Investor Conference in La Jolla, CA, on February 28^th to March 2^nd, 2023

February 1, 2023

Events

SAN DIEGO, February 1, 2023 – Meet selectION’s management team for an update on selectION’s best-in-class ion channel blockers and the status of the clinical work in atopic dermatitis.

Meet selectION, Inc. at the 41^stAnnual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 9^th to 12^th, 2023

December 1, 2022

Events

SAN DIEGO, December 1, 2022 – Meet Antonius Schuh, Ph.D. (CEO), and Steve Zaniboni (CFO) for an update on selectION’s clinical work in atopic dermatitis.

Meet selectION, Inc. at the BioEurope 2022 Partnering Conference in Leipzig on October 24^th to 26^th, 2022

October 1, 2022

Events

SAN DIEGO, October 1, 2022 – Meet Antonius Schuh, Ph.D. (CEO), and Andreas Klostermann, Ph.D. (CSO) for an update on selectION’s best-in-class ion channel blockers and the status of the…

selectION, Inc. Initiates Dosing in Atopic Dermatitis Patients

September 12, 2022

News

Phase 1b trial is designed to evaluate safety, tolerability, and efficacy of potent Kv1.3 blocker in T-cell mediated autoimmunity – San Diego, CA, USA, and Munich, Germany – September 12,…

News & Events

Meet selectION, Inc. at the 42^ndAnnual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 8^th to 11^th, 2024

Meet selectION, Inc. at the BIO-Europe in Munich, on November 6^th to 8^th, 2023

BioWorld: Selection waits on efficacy data from trial of Kv1.3 ion channel blocker in atopic dermatitis

selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis

Meet selectION, Inc. at the BIO International Convention in Boston, on June 5^th to 8^th, 2023

Meet selectION, Inc. at the BIO-EUROPE SPRING Conference in Basel, Switzerland, on March 20^th to March 22^nd, 2023

Meet selectION, Inc. at the Global Life Science Partnering & Investor Conference in La Jolla, CA, on February 28^th to March 2^nd, 2023

Meet selectION, Inc. at the 41^stAnnual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 9^th to 12^th, 2023

Meet selectION, Inc. at the BioEurope 2022 Partnering Conference in Leipzig on October 24^th to 26^th, 2022

selectION, Inc. Initiates Dosing in Atopic Dermatitis Patients

Search News

Categories

Recent News

About

Recent News

Contact